Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Interim Management Statement

14 Nov 2008 11:14

RNS Number : 1896I
Aberdeen Grwth Opp VCT2 PLC
14 November 2008
 



Aberdeen Growth Opportunities VCT PLC 

Interim Management Statement 

1. Net Asset Value

Ordinary share net asset value (NAV) of 93.1p at 30 September 2008 (101.5p at 30 June 2008)

S Ordinary share net asset value (NAV) of 96.7p at 30 September 2008 (98.7p at 30 June 2008)

The NAVs shown above are unaudited and reflect the closing bid prices of quoted securities at 30 September 2008. Unlisted companies are normally valued on a six-monthly basis and the NAVs include the Directors' valuations of unlisted investments as at 30 June 2008 adjusted for material developments within the portfolios since that date.  

2. Investments and disposals

For the Ordinary share portfolio, during the quarter ended 30 September 2008, investments totalling £150,000 were made in four unlisted or AIM-quoted companies. During the same period, disposals of three unlisted or AIM quoted investments generated aggregate proceeds of £376,452 against cost of £232,452.

For the S share portfolio, during the quarter ended 30 September 2008, investments totalling £115,000 were made in three unlisted or AIM-quoted companies. During the same period, disposals of three AIM-quoted investments generated aggregate proceeds of £60,221 against cost of £96,389.

There were no other material transactions during the period under review. 

3. Recent developments 

No further investments have been made between 30 September 2008 and the date of this statement. During that period, disposals generated proceeds of £94,699 and £67,888 for the Ordinary share portfolio and C share portfolio respectively against costs of £87,847 and £59,161.

The Board is not aware of any other events or transactions that have taken place between 30 September 2008 and the date of publication of this statement and which would have had a material impact on the financial position of the Company. 

Issued on behalf of the Board

Aberdeen Asset Management PLC, Secretary

14 November 2008

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGUGBUGUPRGGC
Date   Source Headline
20th May 202210:03 amRNSIssue of Equity
13th May 20223:24 pmRNSStatement re Dividend Investment Scheme
12th May 20223:19 pmRNSNet Asset Value(s)
11th May 20222:01 pmRNSResult of AGM & Directorate Change
26th Apr 202212:34 pmRNSIssue of Supplementary Prospectus
5th Apr 20226:30 pmRNSIssue of Equity
23rd Mar 20225:10 pmRNSDirector/PDMR Shareholding
23rd Mar 20225:05 pmRNSIssue of Equity
22nd Mar 20223:23 pmRNSAnnual Financial Report
16th Mar 20223:32 pmRNSTransaction in Own Shares
15th Mar 20223:09 pmRNSTransaction in Own Shares
11th Mar 202211:41 amRNSIssue of Equity - Dividend Investment Scheme
10th Mar 202211:30 amRNSIssue of Equity
10th Mar 202211:20 amRNSStatement re Dividend Investment Scheme
10th Mar 202211:04 amRNSNet Asset Value and Proposed Final Dividend
18th Feb 20225:32 pmRNSIssue of Equity - Replacement Announcement
7th Feb 202212:49 pmRNSDirector/PDMR Shareholding
7th Feb 202212:48 pmRNSDirector/PDMR Shareholding
7th Feb 202210:51 amRNSIssue of Equity
4th Feb 20229:46 amRNSNet Asset Value(s)
31st Jan 20224:25 pmRNSStatement re Offer for Suscription
10th Jan 202212:43 pmRNSStatement re Offer for Subscription
5th Jan 202210:35 amRNSDividend Declaration
2nd Dec 20213:37 pmRNSTransaction in Own Shares
11th Nov 20213:25 pmRNSNet Asset Value(s)
20th Oct 20214:44 pmRNSResult of General Meeting
1st Oct 20219:22 amRNSIssue of Equity
28th Sep 20213:22 pmRNSStatement re Dividend Investment Scheme
20th Sep 20215:42 pmRNSStatement re Change of Registrar
20th Sep 20215:21 pmRNSPublication of a Prospectus
7th Sep 20214:47 pmRNSTransaction in Own Shares
31st Aug 20213:27 pmRNSTransaction in Own Shares
27th Aug 20213:23 pmRNSHalf-year Report
24th Aug 20213:42 pmRNSTransaction in Own Shares
23rd Aug 20213:14 pmRNSTransaction in Own Shares
19th Aug 20213:04 pmRNSStatement re NAV and Interim Dividend
16th Jun 20213:16 pmRNSStatement re Offer for Subscription
24th May 20214:45 pmRNSTransaction in Own Shares
21st May 202111:02 amRNSIssue of Equity
17th May 20214:32 pmRNSStatement re Dividend Investment Scheme
12th May 20214:08 pmRNSNet Asset Value(s)
12th May 202112:37 pmRNSResult of AGM
9th Apr 20215:48 pmRNSAnnual Financial Report
24th Feb 20214:20 pmRNSTransaction in Own Shares
23rd Feb 20214:18 pmRNSTransaction in Own Shares
17th Feb 20214:37 pmRNSStatement re NAV and Final Dividend
8th Dec 20203:27 pmRNSTransaction in Own Shares
17th Nov 20204:26 pmRNSTransaction in Own Shares
16th Nov 20204:52 pmRNSTransaction in Own Shares
11th Nov 20205:01 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.